Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Complete antithrombin deficiency in mice results in embryonic lethality
Kazuhiro Ishiguro, … , Takashi Muramatsu, Hidehiko Saito
Kazuhiro Ishiguro, … , Takashi Muramatsu, Hidehiko Saito
Published October 1, 2000
Citation Information: J Clin Invest. 2000;106(7):873-878. https://doi.org/10.1172/JCI10489.
View: Text | PDF
Article Article has an altmetric score of 6

Complete antithrombin deficiency in mice results in embryonic lethality

  • Text
  • PDF
Abstract

Antithrombin is a plasma protease inhibitor that inhibits thrombin and contributes to the maintenance of blood fluidity. Using targeted gene disruption, we investigated the role of antithrombin in embryogenesis. Mating mice heterozygous for antithrombin gene (ATIII) disruption, ATIII+/–, yielded the expected Mendelian distribution of genotypes until 14.5 gestational days (gd). However, approximately 70% of the ATIII–/– embryos at 15.5 gd and 100% at 16.5 gd had died and showed extensive subcutaneous hemorrhage. Histological examination of those embryos revealed extensive fibrin(ogen) deposition in the myocardium and liver, but not in the brain or lung. Furthermore, no apparent fibrin(ogen) deposition was detected in the extensive hemorrhagic region, suggesting that fibrinogen might be decreased due to consumptive coagulopathy and/or liver dysfunction. These findings suggest that antithrombin is essential for embryonic survival and that it plays an important role in regulation of blood coagulation in the myocardium and liver.

Authors

Kazuhiro Ishiguro, Tetsuhito Kojima, Kenji Kadomatsu, Yukiko Nakayama, Akira Takagi, Misao Suzuki, Naoki Takeda, Masafumi Ito, Koji Yamamoto, Tadashi Matsushita, Kazuo Kusugami, Takashi Muramatsu, Hidehiko Saito

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2019 2018 2016 2015 2014 2013 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 Total
Citations: 2 3 2 4 3 2 5 2 3 5 2 1 1 7 4 2 3 2 2 2 3 1 61
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (61)

Title and authors Publication Year
Mechanism of antithrombin deficiency due to the novel variant C32W in the C-terminus of the signal peptide.
Kikuchi Y, Nagaya S, Togashi T, Imai Y, Togashi M, Araiso Y, Nishiuchi T, Morishita E
International journal of hematology 2025
Real-time imaging of blood coagulation and angiogenesis during development in a zebrafish model of type I antithrombin deficiency.
Imai Y, Ozaki S, Noda T, Kobayashi I, Sugitani K, Kasashima S, Morishita E, Araiso Y
Scientific reports 2025
Long-range and real-time PCR identification of a large SERPINC1 deletion in a patient with antithrombin deficiency.
Matsumoto S, Uchiumi T, Ueyanagi Y, Noda N, Sakai A, Hotta T, Kato K, Ohga S, Kunisaki Y, Kang D
International Journal of Hematology 2024
SCAR-6 elncRNA locus epigenetically regulates PROZ and modulates coagulation and vascular function.
Ranjan G, Sehgal P, Scaria V, Sivasubbu S
EMBO reports 2024
Loss of protein C vs protein S results in discrepant thrombotic phenotypes
Ku CJ, Yu X, Zhao QY, Grzegorski SJ, Daniel JG, Ferguson AC, Shavit JA
Blood Advances 2024
Antithrombin diagnostics by mass spectrometry: Development and analytical validation of a next-generation test
Kruijt M, Treep MM, Cobbaert CM, Ruhaak LR
Research and Practice in Thrombosis and Haemostasis 2023
Comparison of antithrombin activity assays in detection of patients with heparin binding site antithrombin deficiency: systematic review and meta-analysis
Rojnik T, Sedlar N, Turk N, Kastrin A, Debeljak M, Božič Mijovski M
Scientific Reports 2023
Anticoagulant SERPINs: Endogenous Regulators of Hemostasis and Thrombosis
S Grover, N Mackman
Frontiers in Cardiovascular Medicine 2022
Fishing for answers to hemostatic and thrombotic disease: Genome editing in zebrafish
Raghunath A, Ferguson AC, Shavit JA
Research and Practice in Thrombosis and Haemostasis 2022
Five Challenging Cases of Hereditary Antithrombin Deficiency Characterized by Thrombosis or Complicated Pregnancy.
Roberts JC, von Drygalski A, Zhou JY, Rodgers GM, Ansteatt K, Tarantino MD
Journal of blood medicine 2022
Two SERPINC1 variants affecting N-glycosylation of Asn224 cause severe thrombophilia not detected by functional assays
de la Morena-Barrio ME, Suchon P, Jacobsen EM, Iversen N, Miñano A, de la Morena-Barrio B, Bravo-Pérez C, Padilla J, Cifuentes R, Asenjo S, Deleuze JF, Trégouët DA, Lozano ML, Vicente V, Sandset PM, Morange PE, Corral J
Blood 2022
Serpins in Hemostasis as Therapeutic Targets for Bleeding or Thrombotic Disorders
EP Bianchini, C Auditeau, M Razanakolona, M Vasse, D Borgel
Frontiers in Cardiovascular Medicine 2021
Antithrombin and Its Role in Host Defense and Inflammation
C Schlömmer, A Brandtner, M Bachler
International journal of molecular sciences 2021
Downregulation of microRNA-200c-3p alleviates the aggravation of venous thromboembolism by targeting serpin family C member 1
X Jian, D Yang, L Wang, H Wang
Bioengineered 2021
Analysis of factor V in zebrafish demonstrates minimal levels needed for early hemostasis
AC Weyand, SJ Grzegorski, MS Rost, KI Lavik, AC Ferguson, M Menegatti, CE Richter, R Asselta, S Duga, F Peyvandi, JA Shavit
Blood Advances 2019
Incidence and features of thrombosis in children with inherited antithrombin deficiency.
de la Morena-Barrio B, Orlando C, de la Morena-Barrio ME, Vicente V, Jochmans K, Corral J
Haematologica 2019
Expression and functional characterization of two natural heparin-binding site variants of antithrombin
P Dinarvand, L Yang, BO Villoutreix, AR Rezaie
Journal of Thrombosis and Haemostasis 2018
Cooperative Interactions of Three Hotspot Heparin Binding Residues Are Critical for Allosteric Activation of Antithrombin by Heparin
B Richard, R Swanson, G Izaguirre, ST Olson
Biochemistry 2018
Advances and innovations in haemophilia treatment
R Peters, T Harris
Nature Reviews Drug Discovery 2018
Suppressing protein Z‐dependent inhibition of factor Xa improves coagulation in hemophilia A
TJ Girard, NM Lasky, K Grunz, GJ Broze
Journal of Thrombosis and Haemostasis 2018
MPI-CDG with transient hypoglycosylation and antithrombin deficiency
ME de la Morena-Barrio, E Wypasek, D Owczarek, A Miñano, V Vicente, J Corral, A Undas
Haematologica 2018
Identification of Regulatory Mutations in SERPINC1 Affecting Vitamin D Response Elements Associated with Antithrombin Deficiency
M Toderici, ME de la Morena-Barrio, J Padilla, A Miñano, AI Antón, JA Iniesta, MT Herranz, N Fernández, V Vicente, J Corral, J Wang
PloS one 2016
Inhibitory serpins. New insights into their folding, polymerization, regulation and clearance
PG Gettins, ST Olson
Biochemical Journal 2016
The influence of the amyloid ß-protein and its precursor in modulating cerebral hemostasis
WE van Nostrand
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2015
Modeling Disorders of Blood Coagulation in the Zebrafish
CA Kretz, AC Weyand, JA Shavit
Current Pathobiology Reports 2015
Saturation Mutagenesis of the Antithrombin Reactive Center Loop P14 Residue Supports a Three-step Mechanism of Heparin Allosteric Activation Involving Intermediate and Fully Activated States
R Roth, R Swanson, G Izaguirre, SC Bock, PG Gettins, ST Olson
The Journal of biological chemistry 2015
Targeted mutagenesis of zebrafish antithrombin III triggers disseminated intravascular coagulation and thrombosis, revealing insight into function
Y Liu, CA Kretz, ML Maeder, CE Richter, P Tsao, AH Vo, MC Huarng, T Rode, Z Hu, R Mehra, ST Olson, JK Joung, JA Shavit
Blood 2014
Zebrafish as a model system for the study of hemostasis and thrombosis:
AC Weyand, JA Shavit
Current Opinion in Hematology 2014
Cytoprotective-selective activated protein C therapy for ischaemic stroke:
LO Mosnier, BV Zlokovic, JH Griffin
2014
Conformational Activation of Antithrombin by Heparin Involves an Altered Exosite Interaction with Protease
G Izaguirre, S Aguila, L Qi, R Swanson, R Roth, AR Rezaie, PG Gettins, ST Olson
The Journal of biological chemistry 2014
A complex genomic abnormality found in a patient with antithrombin deficiency and autoimmune disease-like symptoms.
Kato I, Takagi Y, Ando Y, Nakamura Y, Murata M, Takagi A, Murate T, Matsushita T, Nakashima T, Kojima T
International Journal of Hematology 2014
Plasmodium falciparum picks (on) EPCR
WC Aird, LO Mosnier, RM Fairhurst
Blood 2013
Control of post-translational modifications in antithrombin during murine post-natal development by miR-200a
R Teruel, I Martínez-Martínez, JA Guerrero, R González-Conejero, ME de la Morena-Barrio, S Salloum-Asfar, AB Arroyo, S Águila, N García-Barberá, A Miñano, V Vicente, J Corral, C Martínez
Journal of Biomedical Science 2013
Matriptase is inhibited by extravascular antithrombin in epithelial cells but not in most carcinoma cells
FP Chou, H Xu, MS Lee, YW Chen, OX Richards, R Swanson, ST Olson, MD Johnson, CY Lin
American journal of physiology. Cell physiology 2011
Molecular mechanisms of antithrombin-heparin regulation of blood clotting proteinases. a paradigm for understanding proteinase regulation by serpin family protein proteinase inhibitors
ST Olson, B Richard, G Izaguirre, S Schedin-Weiss, PG Gettins
Biochimie 2010
Embryonic lethal coagulopathy and vascular dysgenesis in mice lacking Protein S
Tal Burstyn-Cohen, Mary Jo Heeb, Greg Lemke
Journal of Clinical Investigation 2009
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009
AbetaPP/APLP2 family of Kunitz serine proteinase inhibitors regulate cerebral thrombosis
F Xu, ML Previti, MT Nieman, J Davis, AH Schmaier, WE van Nostrand
The Journal of neuroscience : the official journal of the Society for Neuroscience 2009
Tissue factor-dependent coagulation contributes to alpha-naphthylisothiocyanate-induced cholestatic liver injury in mice
JP Luyendyk, GH Cantor, D Kirchhofer, N Mackman, BL Copple, R Wang
American journal of physiology. Gastrointestinal and liver physiology 2009
The signature 3-O-sulfo group of the anticoagulant heparin sequence is critical for heparin binding to antithrombin but is not required for allosteric activation
B Richard, R Swanson, ST Olson
The Journal of biological chemistry 2009
Functional consequences of the prothrombotic SERPINC1 rs2227589 polymorphism on antithrombin levels
AI Antón, R Teruel, J Corral, A Miñano, I Martínez-Martínez, A Ordóñez, V Vicente, B Sánchez-Vega
Haematologica 2009
The Critical Role of Hinge Region Expulsion in the Induced-fit Heparin Binding Mechanism of Antithrombin
Langdown J, Belzar KJ, Savory WJ, Baglin TP, Huntington JA
Journal of Molecular Biology 2009
Vascular dermatan sulfate regulates the antithrombotic activity of heparin cofactor II
L He, TK Giri, CP Vicente, DM Tollefsen
Blood 2008
Protein Z-dependent protease inhibitor deficiency produces a more severe murine phenotype than protein Z deficiency
J Zhang, Y Tu, L Lu, N Lasky, GJ Broze
Blood 2008
Ancestry and evolution of a secretory pathway serpin
A Kumar, H Ragg
BMC Evolutionary Biology 2008
Pharmacokinetics of protein C and antithrombin in the fetal lamb: a model to predict human neonatal replacement dosing
MJ Manco-Johnson, MR Hacker, LJ Jacobson, WW Hay
Neonatology 2008
Accelerated atherogenesis and neointima formation in heparin cofactor II deficient mice
CP Vicente, L He, DM Tollefsen
Blood 2007
Genomic regions that influence plasma levels of inflammatory markers in hypertensive sibships
K Ding, D Feng, M Andrade, TH Mosley, ST Turner, E Boerwinkle, IJ Kullo
Journal of Human Hypertension 2007
L-asparaginase-induced antithrombin type I deficiency: implications for conformational diseases
D Hernández-Espinosa, A Miñano, C Martínez, E Pérez-Ceballos, I Heras, JL Fuster, V Vicente, J Corral
The American Journal of Pathology 2006
A nonsense polymorphism in the protein Z-dependent protease inhibitor increases the risk for venous thrombosis
J Corral, R González-Conejero, JM Soria, JR González-Porras, E Pérez-Ceballos, R Lecumberri, V Roldán, JC Souto, A Miñano, D Hernández-Espinosa, I Alberca, J Fontcuberta, V Vicente
Blood 2006
Antithrombin reduces reperfusion-induced hepatic metastasis of colon cancer cells.
Kurata M, Okajima K, Kawamoto T, Uchiba M, Ohkohchi N
World Journal of Gastroenterology 2006
The heparin-binding site of antithrombin is crucial for antiangiogenic activity
W Zhang, R Swanson, G Izaguirre, Y Xiong, LF Lau, ST Olson
Blood 2005
Inhibition of antithrombin by hyaluronic acid may be involved in the pathogenesis of rheumatoid arthritis
X Chang, R Yamada, K Yamamoto
Arthritis Research & Therapy 2005
Interactions between the innate immune and blood coagulation systems
CT Esmon
Trends in Immunology 2004
Increased Expression of Plasminogen Activator Inhibitor-1 in Cardiomyocytes Contributes to Cardiac Fibrosis after Myocardial Infarction
Takeshita K, Hayashi M, Iino S, Kondo T, Inden Y, Iwase M, Kojima T, Hirai M, Ito M, Loskutoff DJ, Saito H, Murohara T, Yamamoto K
The American Journal of Pathology 2004
Normal levels of anticoagulant heparan sulfate are not essential for normal hemostasis
Sassan HajMohammadi, Keiji Enjoi, Marc Princivalle, Patricia Christi, Miroslav Lech, David Beeler, Helen Rayburn, John J Schwartz, Samad Barzagar, Ariane I. de Agostini, Mark J. Post , Robert D. Rosenberg, Nicholas W. Shworak,
Journal of Clinical Investigation 2003
Heparan sulfate: Antithrombotic or not?
JI Weitz
Journal of Clinical Investigation 2003
Heparin Cofactor II Inhibits Arterial Thrombosis After Endothelial Injury
Li He, Cristina P. Vicente, Randal J. Westrick, Daniel T. Eitzman, and Douglas M. Tollefsen
Journal of Clinical Investigation 2002
Targeted gene disruption of natural anticoagulant proteins in mice
T Kojima
International Journal of Hematology 2002
Mice deficient in heparan sulfate 3-O-sulfotransferase-1: normal hemostasis with unexpected perinatal phenotypes.
Shworak NW, HajMohammadi S, de Agostini AI, Rosenberg RD
Glycoconjugate Journal 2002
Disruption of the protein C anticoagulant pathway in mice by cell type-restricted thrombomodulin gene ablation causes severe thrombosis with juvenile-onset
Berend Isermann, Sara B. Hendrickson, Mark Zogg, Mark Wing, Marjorie Cummiskey, Yaz Y. Kisanuki, Masashi Yanagisawa, Hartmut Weiler
Journal of Clinical Investigation 2001

← Previous 1 2 3 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 1 patents
Referenced in 4 Wikipedia pages
54 readers on Mendeley
See more details